Legal Kratom Extract Can Trigger Opioid-Level Withdrawal, Doctors Report

Key Points:

• The synthetic kratom derivative 7-hydroxymitragynine (7-OH) is significantly more potent than natural kratom and can exceed the potency of morphine, leading to increased health risks and withdrawal symptoms similar to opioids.
• A case study of a 43-year-old man withdrawing from high-dose 7-OH highlights the drug's strong opioid-like effects and the need for medical treatment with buprenorphine and naloxone, alongside supportive care.
• The DEA plans to temporarily schedule 7-OH as a Schedule I substance, reflecting growing concerns about its abuse potential, though regulatory responses vary by state and the impact of criminalization remains uncertain.
• Healthcare professionals are urged to distinguish between natural kratom and concentrated 7-OH products for accurate risk assessment, treatment, and patient counseling, especially given the rapid dependence and withdrawal symptoms linked to 7-OH.
• Despite rising use—estimated at 2 million Americans in 2024—and increasing poison center reports, public awareness and policy regulation of 7-OH lag behind its growing prevalence and associated health risks.